SCHEMBL6992556

SCHEMBL6992556

CC1=C(N)Nc2cc(C=CC(N)=O)ccc2O1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.49
PELI1 Q96FA3 1/20 0.36
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 5/20 0.33
KMT2A Q03164 5/20 0.33
RAB9A P51151 4/20 0.33
MEN1 O00255 3/20 0.33
NPC1 O15118 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP2D6 P10635 2/20 0.33
LMNA P02545 1/20 0.33
PKM P14618 1/20 0.33
ALOX12 P18054 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
HDAC1 Q13547 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6992552 1.00 ALOX5 (0.49) ALOX5PELI1KDM4EALDH1A1MAPT
SCHEMBL6997020 0.77 ALOX5 (0.41) ALOX5KDM4E
SCHEMBL6996415 0.73 PARP1 (0.48) ALOX5
SCHEMBL6996421 0.73 PARP1 (0.48) ALOX5
SCHEMBL6992674 0.72 ALOX5 (0.41) ALOX5PELI1KDM4EALDH1A1KMT2A
SCHEMBL6996806 0.69 ALDH1A1 (0.53) ALOX5KDM4EALDH1A1MAPTKMT2A
SCHEMBL5670589 0.69 AHR (0.39) ALDH1A1MAPTSMN1; SMN2LMNACYP3A4
Hydrochloric Acid SCHEMBL5672533 0.68 AHR (0.38) MAPTKMT2ASMN1; SMN2LMNACYP3A4
SCHEMBL7002378 0.68 PKM (0.47) ALOX5KDM4EALDH1A1MAPTKMT2A
SCHEMBL7988325 0.67 ALDH1A1 (0.36) KDM4EALDH1A1MAPTKMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed
EP-1015437-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2000-07-05 EP disclosed
WO-1999012915-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 1999-03-18 WO disclosed